Region: United States of America

Paul Lin, now managing director of Eagle Forest, aims to provide the licensee’s perspective to arm Via as it navigates a shifting patent pool landscape

23 March 2023

In retrospect, the US R&D and licensing business would surely have preferred to take a hit in order to settle its dispute with Lenovo out of sight and in secret

23 March 2023

In an exclusive interview, IP head Van Nguy reveals her rubric for building a foundational portfolio on emerging tech including a mix of patents, trade secrets and trade dress

22 March 2023

We talked with Greg Benoit, president of the Canadian company that filed the most cases in 2022, strongly favours the Western District of Texas, and has obtained a 96% settlement rate among its terminated cases

20 March 2023

Opinion: Popular attacks on America’s life sciences patent system are highly misleading

18 March 2023

As long as an allegation is made in good faith – meaning not objectively baseless – the First Amendment protects a patent holder’s right to send them

17 March 2023

Surprise intervention of US government has not helped the mRNA company

17 March 2023

Chief Judge Rodney Gilstrap’s standing order, which bans terms like “patent troll” among other things, is expected to benefit clients by saving them money

16 March 2023

Like many others, the bank held thousands of patents as security for loan deals, but almost certainly had no idea of their value – or lack of it

16 March 2023

Chief IP officers at large and small companies – especially life sciences – are closely watching the case which promises to settle debate about what comprises sufficient enablement under Section 112

15 March 2023